ZOOMADLABS - ONE RAW CREATINE PINA COLADA
Food supplement declared in France, decision dated 24 February 2026
ZOOMADLABS - ONE RAW CREATINE PINA COLADA, from Beaufit Sl, is a food supplement declared in France. Status: declared in France, may be marketed. Main ingredients: Créatine monohydrate. None of the rules we check flags an issue with its declared composition.
- Brand
- ZOOMADLABS
- Food business operator placing the product on the market
- Beaufit Sl
- Status
- Declared in France, may be marketed: the authorities did not object to the declaration (this is neither an authorisation nor a safety assessment)
- Form
- Powder
- Daily dose
- 3 g (1 cuillère doseuse) par jour
- Intended populations
- Men and women aged 18 and over
- Not recommended (according to the manufacturer)
- Adolescents (under 18), Breastfeeding women, Pregnant women
- Objectives stated by the manufacturer (these are not authorised claims)
- Sport
- Flavourings
- ANANAS - NOIX DE COCO
Declaration 357856, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 15 November 2026.
Declared composition
Other active ingredients
| Name | Per day |
|---|---|
| Créatine monohydrate | not declared |
Additives
E955, E551, E330
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Has the product changed? Photograph the packaging.
Label warnings
Ne Ras dépasser la dose journalière recommandée. Les compléments alimentaires ne doivent pas se substituer à une alimentation variée et équilibrée et à un mode de vie sain. Ne pas laisser à la portée des jeunes enfants. Déconseillé aux femmes enceintes ou allaitantes. Réservé à l'adulte.
Regulatory points
None of the rules we check applies to the declared ingredients.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Créatine monohydrate
Read the warning, when it applies and the studies cited
Creatine Monohydrate
Route of administration: Oral
Cautions and warnings
When using this product you may gain weight (Volek and Rawson 2004; Bemben et al. 2001; Mihic et al. 2000).
Sources cited by Health Canada (3)
- Bemben MG, Bemben DA, Loftiss DD, Knehans AW. 2001. Creatine supplementation during resistance training in college football athletes. Medicine & Science in Sports & Exercise 33(10):1667-1673.
- Mihic S, MacDonald JR, McKenzie S, Tarnopolsky MA. 2000. Acute creatine loading increases fat-free mass, but does not affect blood pressure, plasma creatinine, or CK activity in men and women. Medicine & Science in Sports and Exercise 32(2):291-296.
- Volek JS, Rawson ES. 2004. Scientific basis and practical aspects of creatine supplementation for athletes. Nutrition 20(7-8):609-614.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a kidney disorder (Pline and Smith 2005; Pritchard and Kalra 1998).
Sources cited by Health Canada (2)
- Pline KA, Smith CL. 2005. The effect of creatine intake on renal function. The Annals of Pharmacotherapy 39(6):1093-1096.
- Pritchard NR, Kalra PA. 1998. Renal dysfunction accompanying oral creatine supplements. The Lancet 351(9111):1252-1253.
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : ZOOMADLABS
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.
Cite this page: CompoAtlas, “ZOOMADLABS - ONE RAW CREATINE PINA COLADA: composition and regulation”, https://compoatlas.com/en/supplements/products/357856-zoomadlabs-one-raw-creatine-pina-colada, updated 15 November 2026.